American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2010; 33,Suppl 1:S62–S69.
2.
NathanDM, KuenenJ, BorgRet al.A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care, 2008; 31:1473–1478.
3.
BorgR, KuenenJC, CarstensenBet al.ADAG Study Group. HbA1(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: The A1C-Derived Average Glucose (ADAG) study. Diabetologia, 2011; 54:69–72.
4.
JanghorbaniM, AminiM. Glycated hemoglobin as a predictor for metabolic syndrome in an Iranian population with normal glucose tolerance. Metab Syndr Relat Disordin press.
5.
AllenDW, SchroederWA, BalogJ. Observations on the chromatographic heterogeneity of normal adult and fetal human hemoglobin. J Am Chem Soc, 1958; 80:1628–1634.
6.
RahbarS, BlumenfeldO, RanneyHM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Comm, 1969; 36:838–843.
7.
BunnHF, HaneyDN, KaminSet al.The biosynthesis of human hemoglobin A1c. J Clin Invest, 1976; 57:1652–1659.
8.
KoenigRJ, PetersonCM, KiloCet al.Hemoglobin A1c as an indicator of the degree of glucose intolerance in diabetes. Diabetes, 1976; 25:230–232.
9.
NathanDM, SingerDE, HurxthalKet al.The clinical information value of the glycosylated hemoglobin assay. N Engl J Med, 1984; 310:341–346.
10.
DiabetesControl. Complications Trial Research Group. Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: A multicenter study. Clin Chem, 1987; 33:2267–2271.
KahnR, FonsecaV. Translating the A1C assay. Editorial. Diabetes Care, 2008; 31:1–4.
13.
SaaddineJB, Fagot-CampagnaA, RolkaDet al.Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care, 2002; 25:1326–1330.
14.
HermanWH, MaY, UwaifoGet al.Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care, 2007; 30:2453–2457.
15.
InzucchiSE. Clinical practice. Diagnosis of diabetes. N Engl J Med, 2012; 367:542–550.
16.
GallagherEJ, LeRoith D, BloomgardenZ. Review of hemoglobin A(1c) in the management of diabetes. J Diabetes, 2009; 1:9–17.
17.
SinhaN, MishraTK, SinghTet al.Effect of iron deficiency anemia on hemoglobin A1c levels. Ann Lab Med, 2012; 32:17–22.
18.
HardikarPS, JoshiSM, BhatDSet al.Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young indians partly explained by hematological factors and iron deficiency anemia. Diabetes Care, 2012; 35:797–802.
19.
MatsumotoH, Murase-MishibaY, YamamotoNet al.Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes. Intern Med, 2012; 51:1315–1321.
20.
JuraschekSP, SteffesMW, MillerER3rdet al.Alternative markers of hyperglycemia and risk of diabetes. Diabetes Care, 2012Aug8[Epub ahead of print]
21.
GrundySM. Does a diagnosis of metabolic syndrome have value in clinical practice?Am J Clin Nutr, 2006; 83:1248–1251.
